Stay updated with breaking news from Interrogative Biology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last week (April 5), the American Association for Cancer Research (AACR) welcomed the industry to the San Diego Convention Center for the AACR Annual Meeting 2024.
BPGbio, an AI-powered biopharma that focuses on oncology, neurology, and rare diseases, is advancing its pancreatic cancer drug BPM 31510 IV after a positive phase 1 and 2a study.
BOSTON, July 25, 2023--BPGbio and VELL Health announced a collaboration to launch a revolutionary global health initiative and improve Type 2 Diabetes outcomes in Guyana.
The company is building off a previous partnership with the agency related to prostate cancer to analyze samples for breast cancer.
/PRNewswire/ -- Dr. Niven Narain is co-founder, president and CEO of BERG, a Boston-based biopharma firm driving next generation drug development by combining...